Clinical trials
Age clinical trials
Below are recruiting age clinical trials, each written for real people, not researchers. We’re tracking 1,305 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT05265273RecruitingPhase 2/Phase 3
Nipocalimab for children with generalized myasthenia gravis
This trial studies nipocalimab, an immune-focused medicine, to see if it can improve generalized myasthenia gravis (gMG) in children ages 2 to under 18. It may help reduce weakness caused by this autoimmune muscle disease, but you must meet specific antibody and health requirements.
Phoenix, ArizonaAges 2–17 - NCT07593677Recruiting
Text Messages to Help You Move More
This study tests whether personalized text messages can motivate adults to exercise more. You'll receive encouraging texts over 6 months and track your activity to see if texting helps you stay active.
Ann Arbor, MichiganAges 40 years+ - NCT07406334RecruitingPhase 1
Pneumococcal booster vaccine study for toddlers
This trial tests a new pneumococcal vaccine as a booster shot in toddlers who already got a full primary series. It aims to see if the booster is safe and produces a strong immune response.
Soweto, Johannesburg, GautengAges 1 year–1.3 years - NCT05514106Enrolling by invitationPhase 4
MIBG heart scan study for aging and neurologic conditions
This Phase 4 study tests how an iodine-based heart scan (a special imaging test) works in people with certain neurologic diagnoses and aging-related conditions. It may help researchers better understand the heart-brain connection in these disorders and improve future care.
Rochester, MinnesotaAges 40–90 - NCT07732530Recruiting
Acupoint Stimulation and Exercise for Pre-Frail Older Adults
This study tests whether combining acupoint stimulation (a type of pressure on specific body points) with exercise can help older adults who are starting to become frail. It aims to improve strength and daily function.
TainanAges 50 years+ - NCT06526260Recruiting
Very Brief Exposure for Social Anxiety in Teens and Young Adults
This study tests a very short, new type of exposure therapy for social anxiety in teens and young adults. Participants will also have a brain scan (MRI) to see how the therapy affects the brain.
Los Angeles, CaliforniaAges 16–22 - NCT05766839RecruitingPhase 2
Patiromer for high potassium in children under 12
This trial tests a medication called patiromer, which is a powder that helps lower high potassium levels in children under 12. It may be an option for children who have high potassium and can take medicine by mouth or through a feeding tube.
Aurora, ColoradoAges birth–11 years - NCT07729930Recruiting
Creatine supplement study for healthy middle-aged women
This study is testing a creatine supplement (a substance that may help with energy and muscle function) in healthy middle-aged women. You may join if you are between 35 and 65, a non-smoker, and have a certain activity level.
LoughboroughAges 35–65 - NCT06444594Enrolling by invitationEarly Phase 1
Skin cream study for nerve channels
This study tests how certain skin creams affect nerve channels in the skin. It may help find better ways to treat pain or sensitivity.
University Park, PennsylvaniaAges 18–85 - NCT07662148RecruitingPhase 1
Testing the safety of BIIB144 in healthy adults
This trial tests a single dose of an experimental drug (BIIB144) in healthy adults to see if it is safe and how the body handles it. You would receive either the drug or a placebo (inactive shot) and be closely monitored.
Las Vegas, NevadaAges 18–55 - NCT07367282RecruitingPhase 4
Faricimab for newly diagnosed wet age-related macular degeneration
This study tests if faricimab, an injectable eye medication, can improve vision in people with a newly diagnosed form of wet age-related macular degeneration (AMD). It is for patients who have not yet received treatment for this condition.
SeongnamAges 50 years+ - NCT07629739Recruiting
Exercise program for seniors who want to be more active
This study helps adults 65 and older who are not very active to start a safe, moderate-intensity exercise program. It focuses on whether exercising at home with guidance can improve health and fitness.
Atlanta, GeorgiaAges 65 years+ - NCT06915233RecruitingPhase 3
MACI for ankle cartilage defects in adults
This trial tests a treatment called MACI for people with damaged cartilage in their ankle. It uses your own cells to grow new cartilage, which may help reduce pain and improve how you can use your ankle.
Sacramento, CaliforniaAges 17–65 - NCT06807268RecruitingPhase 3
A study of abrocitinib for children ages 6–11 with eczema
This trial tests a daily pill called Abrocitinib to see if it can help children ages 6 to 11 with moderate-to-severe eczema that hasn't gotten better with creams or ointments. Eczema (also called atopic dermatitis) causes itchy, red skin, and this medicine might calm the immune response to reduce itching and rashes.
Birmingham, AlabamaAges 6–11 - NCT06807281RecruitingPhase 3
Abrocitinib for children with eczema: long-term study
This study tests the long-term safety and effectiveness of abrocitinib (Cibinqo) for children aged 6 to 12 with moderate to severe eczema that hasn't improved with creams. It may help their skin clear and reduce itching.
Birmingham, AlabamaAges 2–11 - NCT07430488Recruiting
Reading a book to help emotions after hysterectomy
This trial tests if reading a personal story about hysterectomy can help women of childbearing age manage their emotions after surgery. It aims to see if this simple activity reduces stress and improves emotional well-being.
BordeauxAges 18–42 - NCT07285005RecruitingPhase 3
Study of an oral drug for venous, lymphatic, and certain overgrowth syndromes
This trial tests whether the study drug KP-001 can help reduce symptoms like pain, fatigue, or bleeding caused by certain vascular malformations (abnormal blood vessel growths) that can't be surgically removed or haven't responded to other treatments. It's for people age 2 and older with specific conditions such as common venous malformations, lymphatic malformations, or KTS/CLOVES syndrome.
Charleston, South CarolinaAges 2 years+ - NCT04798690Recruiting
Long-term growth injections for short children
This trial studies the long-term safety and effectiveness of Growtropin®-II, a growth hormone–type injection, in children who are short due to certain causes. It may help your child’s growth over time, while also closely tracking side effects.
Seoul, Seodaemun-guAges 2 years+ - NCT07670377RecruitingPhase 1
Drug interaction study of GSK3772701 in healthy adults aged 18-55
This trial tests how a new drug (GSK3772701) interacts with another common drug (midazolam) in healthy volunteers. It aims to see if one affects how the other works in the body and will help determine safe dosing for future studies.
Miami, FloridaAges 18–55 - NCT06500702RecruitingPhase 2
Study of three drugs for FSGS or minimal change disease
This study tests three experimental drugs (frexalimab, brivekimig, and rilzabrutinib) for people ages 16 to 75 with a type of kidney disease called primary FSGS or minimal change disease. The goal is to see if these drugs can reduce protein in your urine and help protect your kidneys.
Birmingham, AlabamaAges 16–75 - NCT06659445RecruitingPhase 2
Study of ONL1204 for geographic atrophy in dry AMD
This study tests an investigational medicine called ONL1204 given as an injection into the eye for people with a form of advanced dry age-related macular degeneration called geographic atrophy. The goal is to see if it can slow vision loss.
Gilbert, ArizonaAges 55 years+ - NCT07708844Recruiting
Connecting older adults to reduce loneliness
This study tests a program to help older adults who feel lonely connect with others. It aims to see if structured activities can improve well-being.
Evanston, IllinoisAges 55 years+ - NCT06237127Recruiting
Goji berries vs. fiber for age-related macular degeneration
This study compares the effects of eating goji berries versus taking fiber wafers on age-related macular degeneration (AMD). It looks at whether goji berries or fiber can help slow down the eye condition, especially for people with a family history of AMD.
Sacramento, CaliforniaAges 65–95 - NCT07708935Recruiting
Study of young patients with solid tumors in China
This study looks at young people (40 or younger at diagnosis) with solid tumors in China. It aims to collect real-world information about their treatments and outcomes to find patterns that could help improve care.
ShanghaiAges 18–80
Hear when a new Age trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for age?
- Yes. Clin2 currently lists 1,305 recruiting age studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a age trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a age trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.